GENEIQ Trademark

Trademark Overview

On Wednesday, April 8, 2020, a trademark application was filed for GENEIQ with the United States Patent and Trademark Office. The USPTO has given the GENEIQ trademark a serial number of 88863743. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Tuesday, December 13, 2022. This trademark is owned by GeneIQ, LLC. The GENEIQ trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical and clinical testing for diagnostic or treatment purposes; genetic testing for medical purposes; pharmacogenomics testing for medical purposes; medical testing for diagnostic or treatment purposes, namely, for customization of prescriptions and dosages; providing medical information to patients and physicians, pharmacists, and other healthcare professionals in the form of pharmacogentic data, analysis and reports, and reports in the field of pharmacogenetics, pharmacogenomics, drug-gene interactions as well as drug-drug-gene interactions; molecular testing for cancer and for respiratory drug-gene interactions, for medical purposes; all of the foregoing expressly excluding providing temporary use of a web-based software application for collecting, managing and analyzing healthcare data
geneiq

General Information

Serial Number88863743
Word MarkGENEIQ
Filing DateWednesday, April 8, 2020
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateTuesday, December 13, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkGENE IQ; GENE I Q; GENE INTELLIGENCE QUOTIENT
Goods and ServicesMedical and clinical testing for diagnostic or treatment purposes; genetic testing for medical purposes; pharmacogenomics testing for medical purposes; medical testing for diagnostic or treatment purposes, namely, for customization of prescriptions and dosages; providing medical information to patients and physicians, pharmacists, and other healthcare professionals in the form of pharmacogentic data, analysis and reports, and reports in the field of pharmacogenetics, pharmacogenomics, drug-gene interactions as well as drug-drug-gene interactions; molecular testing for cancer and for respiratory drug-gene interactions, for medical purposes; all of the foregoing expressly excluding providing temporary use of a web-based software application for collecting, managing and analyzing healthcare data

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 15, 2020
Primary Code044
First Use Anywhere DateSaturday, September 1, 2018
First Use In Commerce DateTuesday, January 1, 2019

Trademark Owner History

Party NameGeneIQ, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressThe Colony, TX 75056

Trademark Events

Event DateEvent Description
Wednesday, December 14, 2022ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Wednesday, December 14, 2022ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Tuesday, December 13, 2022ABANDONMENT - AFTER EX PARTE APPEAL
Tuesday, December 13, 2022EXPARTE APPEAL TERMINATED
Thursday, September 29, 2022EX PARTE APPEAL-REFUSAL AFFIRMED
Thursday, July 28, 2022REPLY BRIEF FILED - CHECK TTAB FILES
Thursday, June 23, 2022NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Thursday, June 23, 2022EXAMINERS STATEMENT E-MAILED
Thursday, June 23, 2022EXAMINERS STATEMENT - COMPLETED
Monday, June 13, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, April 11, 2022JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, January 10, 2022NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Monday, January 10, 2022ACTION DENYING REQ FOR RECON E-MAILED
Monday, January 10, 2022ACTION CONTINUING FINAL - COMPLETED
Wednesday, October 27, 2021EX PARTE APPEAL-INSTITUTED
Wednesday, October 27, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, October 26, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, October 26, 2021EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, October 26, 2021PETITION GRANTED - TTAB APPEAL FILED
Monday, October 25, 2021ASSIGNED TO PETITION STAFF
Wednesday, October 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 6, 2021TEAS PETITION TO REVIVE RECEIVED
Monday, August 9, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, August 6, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 18, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 18, 2021FINAL REFUSAL E-MAILED
Monday, January 18, 2021FINAL REFUSAL WRITTEN
Tuesday, December 22, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 21, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020NON-FINAL ACTION WRITTEN
Friday, June 26, 2020ASSIGNED TO EXAMINER
Wednesday, April 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 11, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

geneiq medical testing purposes drug gene interactions healthcare providing data reports